Executive Summary
This digest covers $2.17 billion in government obligations across 8 contracts, with only 2 defense-related awards (totaling ~$569K from DHS/ICE) and 6 civilian contracts dominating the aggregate. The highest-conviction signal is MAXIMUS FEDERAL SERVICES' $892.8 million firm-fixed-price contract with the Department of Education for debt management, representing a long-term, competitive win that underscores sustained federal investment in student loan collections.
A key risk is the short-duration, high-concentration exposure for UnitedHealth Group's OptumRx, which won two $106 million VA delivery orders for a single quarter each, creating lumpy revenue and margin pressure under fixed-price terms. Investors should monitor MAXIMUS for follow-on renewals and UnitedHealth for VA Q2-Q4 PBM awards to assess recurring revenue stability.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Deobligations Alert digest from August 21, 2026.
Investment Signals (5)
- MAXIMUS Wins $892.8M Education Dept Contract for Debt Management (HIGH)▲
MAXIMUS FEDERAL SERVICES secured a $892.8 million firm-fixed-price contract with the Department of Education for debt management and collections systems, with $544.2 million already outlaid, indicating strong execution and a multi-year revenue stream of ~$69.5 million annually.
- Navarro Research Secures $427.6M DOE Contract for Legacy Management (HIGH)▲
Navarro Research and Engineering won a $427.6 million cost-plus-award-fee contract from the Department of Energy for long-term surveillance and maintenance, with $330.5 million in potential future revenue, benefiting from small business set-aside advantages.
- Gulfstream Aerospace (General Dynamics) Wins $251M NOAA Aircraft Contract (HIGH)▲
Gulfstream Aerospace secured a $251.1 million firm-fixed-price contract from NOAA for G550 aircraft, with $98.5 million outlaid, strengthening General Dynamics' government aviation backlog through 2028.
- Fort Myer Construction Wins $173M DOT Highway Contract (HIGH)▲
Fort Myer Construction Corp secured a $173 million fixed-price with economic price adjustment contract from the Federal Highway Administration, with $161 million already outlaid, signaling strong execution and inflation protection.
- UnitedHealth Group's OptumRx Faces Lumpy Revenue from Two $106M VA Delivery Orders (HIGH)▲
OptumRx won two $106.3 million firm-fixed-price delivery orders from the VA for pharmacy benefit management, each for a single quarter (Q1 FY25 and Q2 FY25), with no outlays yet, creating concentrated revenue risk and margin pressure under fixed-price terms.
Risk Flags (4)
- Concentration [HIGH RISK]▼
UnitedHealth Group's OptumRx has two $106M VA delivery orders for single quarters, creating lumpy revenue and execution risk if claims volume spikes under fixed-price terms.
- Execution [MEDIUM RISK]▼
MAXIMUS's $892.8M firm-fixed-price contract with the Department of Education carries performance risk if cost overruns exceed estimates, though $544.2M outlaid suggests successful execution to date.
- Budget [MEDIUM RISK]▼
Navarro Research's $427.6M DOE contract has only $97.1M outlaid (~23%), indicating potential for delayed or reduced spending if DOE budgets for the Office of Legacy Management face cuts.
- Competition [MEDIUM RISK]▼
Fort Myer Construction's $173M DOT contract ends in 2026, and the full-and-open competition nature means re-compete risk is high, with potential for margin compression from new bidders.
Opportunities (3)
- ◆
MAXIMUS's $892.8M Education contract positions it for follow-on renewals in federal debt management, given the multi-year performance period through July 2026 and $544.2M already outlaid.
- ◆
Navarro Research's $427.6M DOE contract as a small disadvantaged business set-aside provides a competitive moat for future DOE legacy management awards, with $330.5M in potential future revenue.
- ◆
Lockheed Martin's $568K DHS/ICE purchase order for receivers, awarded non-competed under SAP, could signal a broader sole-source relationship for specialized communication equipment in homeland security.
Sector Themes (3)
- ◆
The largest contracts in this digest are from civilian agencies: $892.8M from Education for debt management (MAXIMUS) and $212.6M from VA for PBM services (UnitedHealth), indicating sustained federal investment in operational services rather than defense technology.
- ◆
Navarro Research's $427.6M DOE contract for long-term surveillance and maintenance of former nuclear sites highlights ongoing federal commitment to environmental cleanup, with cost-plus pricing reducing contractor risk.
- ◆
Fort Myer Construction's $173M DOT contract with economic price adjustment demonstrates federal infrastructure spending with built-in inflation protection, supporting margin stability for contractors.
Watch List (4)
- 👁
{"entity" => "MAXIMUS INC", "reason" => "Won $892.8M Education contract with $544.2M outlaid; contract ends July 2026, making renewal a key catalyst.", "trigger" => "Contract modification or renewal announcement before July 2026"}
- 👁
{"entity" => "UnitedHealth Group (OptumRx)", "reason" => "Two $106M VA delivery orders for single quarters; no outlays yet, creating lumpy revenue risk.", "trigger" => "VA Q2-Q4 FY25 PBM award announcements or outlay status updates"}
- 👁
{"entity" => "General Dynamics (Gulfstream Aerospace)", "reason" => "$251M NOAA G550 contract through 2028 with $98.5M outlaid; monitor for modifications or follow-on orders.", "trigger" => "NOAA budget allocations for aircraft modernization or contract modifications"}
- 👁
{"entity" => "Fort Myer Construction Corp", "reason" => "$173M DOT contract ends 2026 with $161M outlaid; re-compete risk is high.", "trigger" => "DOT full-and-open award announcements for similar highway projects"}
Get daily alerts with 5 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 8 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Deobligations Alert
🇺🇸 More from United States
View all →August 22, 2026
New Drug Approvals (Original) — August 22, 2026
New Drug Approvals (Original)
August 22, 2026
Orphan Drug Approvals — August 22, 2026
Orphan Drug Approvals
August 22, 2026
Big Pharma Approvals — August 22, 2026
Big Pharma Approvals
August 22, 2026
NME Blockbuster Approvals — August 22, 2026
NME Blockbuster Approvals